title: Ceftolozane-tazobactam versus levofloxacin in urinary tract infection - Authors' reply.
authors.affiliation: Clinic for Urology, Pediatric Urology and Andrology, Justus-Liebig-University, Giessen 35392, Germany. Electronic address: florian.wagenlehner@chiru.med.uni-giessen.de.
authors.forename: Florian M
authors.initials: FM
authors.lastname: Wagenlehner
authors.affiliation: Merck Sharp and Dohme/Cubist Pharmaceuticals, Lexington, MA, USA.
authors.forename: Obiamiwe
authors.initials: O
authors.lastname: Umeh
authors.affiliation: Michael E DeBakey Veterans Affairs Medical Center and Baylor College of Medicine, Houston, TX, USA.
authors.forename: Rabih O
authors.initials: RO
authors.lastname: Darouiche
mesh_terms: D000892:Anti-Infective Agents, Urinary / Q000008:administration & dosage*; D002511:Cephalosporins / Q000008:administration & dosage*; D005260:Female; D016905:Gram-Negative Bacterial Infections / Q000188:drug therapy*; D016908:Gram-Positive Bacterial Infections / Q000188:drug therapy*; D006801:Humans; D064704:Levofloxacin / Q000008:administration & dosage*; D008297:Male; D010397:Penicillanic Acid / Q000031:analogs & derivatives*; D014552:Urinary Tract Infections / Q000188:drug therapy*
chemical_list: D000892:Anti-Infective Agents, Urinary; D002511:Cephalosporins; D064704:Levofloxacin; D010397:Penicillanic Acid